Regulation of RNA Polymerase II Transcription
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Identification of the Promoter and a Transcriptional Enhancer of The
Proc. Natl. Acad. Sci. USA Vol. 90, pp. 11356-11360, December 1993 Developmental Biology Identification of the promoter and a transcriptional enhancer of the gene encoding L-CAM, a calcium-dependent cell adhesion molecule (gene expression/regulatory sequences/morphogenesis/cadherins) BARBARA C. SORKIN, FREDERICK S. JONES, BRUCE A. CUNNINGHAM, AND GERALD M. EDELMAN The Department of Neurobiology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA 92037 Contributed by Gerald M. Edelman, August 20, 1993 ABSTRACT L-CAM is a calcium-dependent cell adhesion expressed in the dermis, but rather in the adjacent epidermis molecule that is expressed in a characteristic place-dependent (6). pattern during development. Previous studies of ectopic ex- L-CAM mediates calcium-dependent cell-cell adhesion (7) pression of the chicken L-CAM gene under the control of via a homophilic mechanism; i.e., L-CAM on one cell binds heterologous promoters in transgenic mice suggested that directly to L-CAM on apposing cells (8). In all tissues where cis-acting sequences controlling the spatiotemporal expression the molecule is expressed, L-CAM is detected as a trans- patterns ofL-CAM were present within the gene itself. We have membrane protein of 124 kDa (7). Mammalian proteins now examined the L-CAM gene for sequences that control its uvomorulin (9), E-cadherin (10), cell-CAM 120/80 (11), and expression and have found an enhancer within the second Arcl (12) are similar to L-CAM in their biochemical and intron of the gene. A 2.5-kb Kpn I-EcoRI fragment from the functional properties and tissue distributions. -
Molecular Basis of the Function of Transcriptional Enhancers
cells Review Molecular Basis of the Function of Transcriptional Enhancers 1,2, 1, 1,3, Airat N. Ibragimov y, Oleg V. Bylino y and Yulii V. Shidlovskii * 1 Laboratory of Gene Expression Regulation in Development, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia; [email protected] (A.N.I.); [email protected] (O.V.B.) 2 Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia 3 I.M. Sechenov First Moscow State Medical University, 8, bldg. 2 Trubetskaya St., 119048 Moscow, Russia * Correspondence: [email protected]; Tel.: +7-4991354096 These authors contributed equally to this study. y Received: 30 May 2020; Accepted: 3 July 2020; Published: 5 July 2020 Abstract: Transcriptional enhancers are major genomic elements that control gene activity in eukaryotes. Recent studies provided deeper insight into the temporal and spatial organization of transcription in the nucleus, the role of non-coding RNAs in the process, and the epigenetic control of gene expression. Thus, multiple molecular details of enhancer functioning were revealed. Here, we describe the recent data and models of molecular organization of enhancer-driven transcription. Keywords: enhancer; promoter; chromatin; transcriptional bursting; transcription factories; enhancer RNA; epigenetic marks 1. Introduction Gene transcription is precisely organized in time and space. The process requires the participation of hundreds of molecules, which form an extensive interaction network. Substantial progress was achieved recently in our understanding of the molecular processes that take place in the cell nucleus (e.g., see [1–9]). -
Transcriptional Integration of Mitogenic and Mechanical Signals by Myc and YAP
Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH COMMUNICATION rum-mediated and growth factor-mediated cell cycle Transcriptional integration entry (Kelly et al. 1983; Armelin et al. 1984; Roussel of mitogenic and mechanical et al. 1991; Barone and Courtneidge 1995; de Alboran et al. 2001; Trumpp et al. 2001; Perna et al. 2012). This signals by Myc and YAP function of Myc stems from its ability to control the ex- pression of a large fraction of genes involved in cell activa- Ottavio Croci,1,5 Serena De Fazio,1,5 1,5 1,4,5 tion and proliferation. Francesca Biagioni, Elisa Donato, When ectopically expressed in quiescent cells, Myc is Marieta Caganova,1 Laura Curti,1 Mirko Doni,2 able to drive cell cycle progression in the absence of serum Silvia Sberna,1 Deborah Aldeghi,1 (Eilers et al. 1991; Pelengaris et al. 1999). This effect of Chiara Biancotto,1 Alessandro Verrecchia,2 Myc is context-dependent, however, since not all cells or tissues respond to Myc by entering the cell cycle (Jack- Daniela Olivero,3 Bruno Amati,1,2 1 son et al. 1990; Xiao et al. 2001; Murphy et al. 2008). This and Stefano Campaner suggests that a full proliferative response may require the engagement of other TFs, which may respond to different 1Center for Genomic Science of IIT@SEMM (Istituto Italiano di regulatory signals, such as metabolic or mechanical cues. Tecnologia at European School of Molecular Medicine), Recently, YAP has emerged as a key TF in the control of Fondazione Istituto Italiano di Tecnologia (IIT), 20139 Milan, cell growth and organ size in response to a variety of Italy; 2Department of Experimental Oncology, European signals such as cell adhesion, apico–basolateral polarity, Institute of Oncology (IEO), 20139 Milan, Italy; 3Laboratorio di cytoskeletal tension, and mitogens. -
Your Genes, Your Choices
Your Genes, Your Choices: Exploring the Issues Raised by Genetic Research by Catherine Baker Table of Contents Acknowledgments . 6 Introduction . 7 Chapter 1 Martin Needs Medical Treatment (or does he?) . 9 Chapter 2 Priya Should Find Out if She Has Inherited a Fatal Disease (or should she?) . 14 Chapter 3 Howard’s Health Is Up to Him (or is it?) . 26 Chapter 4 Carlos and Mollie Can Have a Perfectly Healthy Baby (or can they?) . 35 Chapter 5 Donita Should Cooperate with the Police (or should she?) . 45 Chapter 6 John and Elsa Will Profit from Biotech Farming (or will they?) . 52 Chapter 7 Dr. Lu’s Patients Have the Right to Be Tall (or do they?) . 62 Chapter 8 Mrs. Fister Can Replace Her Dying Son (or can she?) . 70 Glossary . 81 References . 89 Credits . 81 Science + Literacy for Health Human Genome Project Advisory Board . 93 5 Acknowledgments I am not a science writer by trade. In order to write this book, I first had to study up on genetics and the issues involved. Then I had to try to explain them in a way that other newcomers to the subject could understand, without making terrible errors. It was a difficult task! I am therefore indebted to the members of the AAAS Advisory Panel (listed on page 82). At an all-day meeting in the spring of 1995, they steered my away from my original outline toward the book you find here. Many months later, several panel members provided very useful reviews of the manuscript. For this, I would like to thank Ruth Allen, Jeffrey Botkin, Ron Cole-Turner, Robert Cook-Deegan, and Joan Weiss. -
Structure and Mechanism of the RNA Polymerase II Transcription Machinery
Downloaded from genesdev.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Structure and mechanism of the RNA polymerase II transcription machinery Allison C. Schier and Dylan J. Taatjes Department of Biochemistry, University of Colorado, Boulder, Colorado 80303, USA RNA polymerase II (Pol II) transcribes all protein-coding ingly high resolution, which has rapidly advanced under- genes and many noncoding RNAs in eukaryotic genomes. standing of the molecular basis of Pol II transcription. Although Pol II is a complex, 12-subunit enzyme, it lacks Structural biology continues to transform our under- the ability to initiate transcription and cannot consistent- standing of complex biological processes because it allows ly transcribe through long DNA sequences. To execute visualization of proteins and protein complexes at or near these essential functions, an array of proteins and protein atomic-level resolution. Combined with mutagenesis and complexes interact with Pol II to regulate its activity. In functional assays, structural data can at once establish this review, we detail the structure and mechanism of how enzymes function, justify genetic links to human dis- over a dozen factors that govern Pol II initiation (e.g., ease, and drive drug discovery. In the past few decades, TFIID, TFIIH, and Mediator), pausing, and elongation workhorse techniques such as NMR and X-ray crystallog- (e.g., DSIF, NELF, PAF, and P-TEFb). The structural basis raphy have been complemented by cryoEM, cross-linking for Pol II transcription regulation has advanced rapidly mass spectrometry (CXMS), and other methods. Recent in the past decade, largely due to technological innova- improvements in data collection and imaging technolo- tions in cryoelectron microscopy. -
"The Genecards Suite: from Gene Data Mining to Disease Genome Sequence Analyses". In: Current Protocols in Bioinformat
The GeneCards Suite: From Gene Data UNIT 1.30 Mining to Disease Genome Sequence Analyses Gil Stelzer,1,5 Naomi Rosen,1,5 Inbar Plaschkes,1,2 Shahar Zimmerman,1 Michal Twik,1 Simon Fishilevich,1 Tsippi Iny Stein,1 Ron Nudel,1 Iris Lieder,2 Yaron Mazor,2 Sergey Kaplan,2 Dvir Dahary,2,4 David Warshawsky,3 Yaron Guan-Golan,3 Asher Kohn,3 Noa Rappaport,1 Marilyn Safran,1 and Doron Lancet1,6 1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel 2LifeMap Sciences Ltd., Tel Aviv, Israel 3LifeMap Sciences Inc., Marshfield, Massachusetts 4Toldot Genetics Ltd., Hod Hasharon, Israel 5These authors contributed equally to the paper 6Corresponding author GeneCards, the human gene compendium, enables researchers to effectively navigate and inter-relate the wide universe of human genes, diseases, variants, proteins, cells, and biological pathways. Our recently launched Version 4 has a revamped infrastructure facilitating faster data updates, better-targeted data queries, and friendlier user experience. It also provides a stronger foundation for the GeneCards suite of companion databases and analysis tools. Improved data unification includes gene-disease links via MalaCards and merged biological pathways via PathCards, as well as drug information and proteome expression. VarElect, another suite member, is a phenotype prioritizer for next-generation sequencing, leveraging the GeneCards and MalaCards knowledgebase. It au- tomatically infers direct and indirect scored associations between hundreds or even thousands of variant-containing genes and disease phenotype terms. Var- Elect’s capabilities, either independently or within TGex, our comprehensive variant analysis pipeline, help prepare for the challenge of clinical projects that involve thousands of exome/genome NGS analyses. -
Promoter Architecture and Sex-Specific Gene Expression In
| INVESTIGATION Promoter Architecture and Sex-Specific Gene Expression in Daphnia pulex R. Taylor Raborn,*,†,1 Ken Spitze,* Volker P. Brendel,*,†,2 and Michael Lynch*,2 *Department of Biology and †School of Informatics and Computing, Indiana University, Bloomington, Indiana 47405 ORCID IDs: 0000-0001-6249-8033 (R.T.R.); 0000-0003-4289-6637 (K.S.); 0000-0002-8055-7508 (V.P.B.) ABSTRACT Large-scale transcription start site (TSS) profiling produces a high-resolution, quantitative picture of transcription initiation and core promoter locations within a genome. However, application of TSS profiling to date has largely been restricted to a small set of prominent model systems. We sought to characterize the cis-regulatory landscape of the water flea Daphnia pulex, an emerging model arthropod that reproduces both asexually (via parthenogenesis) and sexually (via meiosis). We performed Cap Analysis of Gene Expression (CAGE) with RNA isolated from D. pulex within three developmental states: sexual females, asexual females, and males. Identified TSSs were utilized to generate a “Daphnia Promoter Atlas,” i.e., a catalog of active promoters across the surveyed states. Analysis of the distribution of promoters revealed evidence for widespread alternative promoter usage in D. pulex, in addition to a prominent fraction of compactly-arranged promoters in divergent orientations. We carried out de novo motif discovery using CAGE- defined TSSs and identified eight candidate core promoter motifs; this collection includes canonical promoter elements (e.g., TATA and Initiator) in addition to others lacking obvious orthologs. A comparison of promoter activities found evidence for considerable state- specific differential gene expression between states. Our work represents the first global definition of transcription initiation and promoter architecture in crustaceans. -
Escherichia Coli (Gene Fusion/Attenuator/Terminator/RNA Polymerase/Ribosomal Proteins) GERARD BARRY, CATHERINE L
Proc. Natl. Acad. Sci. USA Vol. 76, No. 10, pp. 4922-4926, October 1979 Biochemistry Control features within the rplJL-rpoBC transcription unit of Escherichia coli (gene fusion/attenuator/terminator/RNA polymerase/ribosomal proteins) GERARD BARRY, CATHERINE L. SQUIRES, AND CRAIG SQUIRES Department of Biological Sciences, Columbia University, New York, New York 10027 Communicated by Cyrus Levinthal, July 2, 1979 ABSTRACT Gene fusions constructed in vitro have been regulation could occur (4-7). Yet under certain conditions, used to examine transcription regulatory signals from the operon coordinate of the RNA which encodes ribosomal proteins L10 and L7/12 and the RNA expression polymerase subunits and polymerase P and #I subunits (the rplJL-rpoBC operon). Por- ribosomal proteins is not observed. This is especially true of the tions of this operon, which were obtained by in vitro deletions, rplJL-rpoBC transcription unit which encodes the ribosomal have been placed between the ara promoter and the lacZgene proteins L10 and L7/12 and the RNA polymerase subunits 13 in the gene-fusion plasmid pMC81 developed by M. Casadaban and 13'. For example, only the ribosomal proteins are modulated and S. Cohen. The effect of the inserted DNA segment on the by the stringent regulation system (8, 9) whereas a transient expression of the IacZ gene (in the presence and absence of arabinose) permits the localization of regulatory signals to dis- stimulatory effect of rifampicin is specific for the RNA poly- crete regions of the rpIJL-rpoBC operon. An element that re- merase subunits (10, 11). In addition, different amounts of duces the level of distal gene expression to one-sixth is located mRNA hybridize to the rpl and rpo regions of the rplJL-rpoBC on a fragment which spans the rplL-rpoB intercistronic region. -
The General Transcription Factors of RNA Polymerase II
Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The general transcription factors of RNA polymerase II George Orphanides, Thierry Lagrange, and Danny Reinberg 1 Howard Hughes Medical Institute, Department of Biochemistry, Division of Nucleic Acid Enzymology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854-5635 USA Messenger RNA (mRNA) synthesis occurs in distinct unique functions and the observation that they can as- mechanistic phases, beginning with the binding of a semble at a promoter in a specific order in vitro sug- DNA-dependent RNA polymerase to the promoter re- gested that a preinitiation complex must be built in a gion of a gene and culminating in the formation of an stepwise fashion, with the binding of each factor promot- RNA transcript. The initiation of mRNA transcription is ing association of the next. The concept of ordered as- a key stage in the regulation of gene expression. In eu- sembly recently has been challenged, however, with the karyotes, genes encoding mRNAs and certain small nu- discovery that a subset of the GTFs exists in a large com- clear RNAs are transcribed by RNA polymerase II (pol II). plex with pol II and other novel transcription factors. However, early attempts to reproduce mRNA transcrip- The existence of this pol II holoenzyme suggests an al- tion in vitro established that purified pol II alone was not ternative to the paradigm of sequential GTF assembly capable of specific initiation (Roeder 1976; Weil et al. (for review, see Koleske and Young 1995). -
The Mammalian Phenotype Ontology As a Tool for Annotating, Analyzing and Comparing Phenotypic Information
Open Access Method2004SmithetVolume al. 6, Issue 1, Article R7 The Mammalian Phenotype Ontology as a tool for annotating, comment analyzing and comparing phenotypic information Cynthia L Smith*, Carroll-Ann W Goldsmith*† and Janan T Eppig* Addresses: *The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA. †Massachusetts College of Pharmacy and Health Sciences, School of Pharmacy Manchester, 1260 Elm Street, Manchester, NH 03101, USA. Correspondence: Janan T Eppig. E-mail: [email protected] reviews Published: 15 December 2004 Received: 8 September 2004 Revised: 15 November 2004 Genome Biology 2004, 6:R7 Accepted: 17 November 2004 The electronic version of this article is the complete one and can be found online at http://genomebiology.com/2004/6/1/R7 © 2004 Smith et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), reports which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The<p>Thetativeofresearchand phenotypic RatMammalian trait Genome Mammaliangroups, loci knowledge and mutagenesisPhenotypeDatabase strains Phenotype and thatto Ontology flexiblereconsortia, arepresent (MP) used annota asOntology phenotypicand asa tool models tionsbiological for enables to annotating,of data.</p> individual human domain robust biology analyzingexperts. genotypes.annotation and The and disease. It of MP continues comparingmammalian Ontology The MPto phenotypic isdevelop Ontolphenotypes currentlyogy dynamically supportsinformation used in the by thecontext different via Mouse collaborative of levels mutations,Genome and input Da richness quanti-tabase from Abstract deposited research The Mammalian Phenotype (MP) Ontology enables robust annotation of mammalian phenotypes in the context of mutations, quantitative trait loci and strains that are used as models of human biology and disease. -
Promoter RNA Sequencing
www.nature.com/scientificreports OPEN Promoter RNA sequencing (PRSeq) for the massive and quantitative promoter analysis in vitro Received: 7 August 2018 Shoji Ohuchi1,3, Thorsten Mascher 1 & Beatrix Suess2 Accepted: 1 February 2019 Analysis of promoter strength and specifcity is important for understanding and engineering gene Published: xx xx xxxx regulation. Here, we report an in vitro promoter analysis method that can achieve both massiveness and quantitativeness. In this approach, a pool of single-stranded DNA with a partially randomized promoter sequence to be analyzed is chemically synthesized. Through enzymatic reactions, the randomized sequence will be copied to the downstream region, resulting in a template DNA pool that carries its own promoter information on its transcribed region. After in vitro transcription of the DNA pool with an RNA polymerase of interest, the sequences of the resulting transcripts will be analyzed. Since the promoter strength linearly correlates to the copy number of transcript, the strength of each promoter sequence can be evaluated. A model experiment of T7 promoter variants demonstrated the quantitativeness of the method, and the method was applied for the analysis of the promoter of cyanophage Syn5 RNA polymerase. This method provides a powerful approach for analyzing the complexity of promoter specifcity and discrimination for highly abundant and often redundant alternative sigma factors such as the extracellular function (ECF) sigma factors. Transcription initiation is the key step for controlling gene expression especially in bacterial and archaeal cells. Tus, analysis of promoter strength and specifcity is important for understanding gene regulation. Traditionally, promoter analysis is performed employing in vivo reporter gene fusions [reviewed in1]. -
CG-3'-Rich Region in the Promoter of the Transcriptionally Frequently Silenced RET Protooncogene Lacks Methylated Cytidine Residues
Oncogene (1998) 17, 2573 ± 2583 ã 1998 Stockton Press All rights reserved 0950 ± 9232/98 $12.00 http://www.stockton-press.co.uk/onc A5'-CG-3'-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues Marc Munnes1, Giovanna Patrone2, Birgit Schmitz1, Giovanni Romeo2 and Walter Doer¯er1 1Institut fuÈr Genetik, UniversitaÈtzuKoÈln, D-50931 KoÈln, Germany; and 2UniversitaÁ di Genova, FacoltaÁ di Medicina e Laboratorio di Genetica Molecolare, Istituto G. Gaslini, I-16148 Genova, Italy In a large proportion of familial and sporadic cases of Keywords: HSCR patients; RET protooncogene Hirschsprung disease (HSCR) mutations in the RET promoter; 5'-CG-3'-rich region in the RET promoter (rearranged during transfection) protooncogene have been described. We have investigated the structure of the RET gene promoter and have analysed a region of approximately 1000 nucleotides in its promoter and 5'- Introduction upstream segments for the occurrence of 5-methyldeoxy- cytidine (5-mC) residues by using the bisul®te protocol of The human RET protooncogene is controlled by a the genomic sequencing method. With an estimated promoter harboring several transcription factor sensitivity of about 93% of this technique, not a single binding sites (Itoh et al., 1992), such as four 5-mC residue could be detected in the control region of a tandemly repeated GC-boxes (Dynan and Tjian, gene that seems to be silenced or exhibit low activity in 1985), an ETF binding site (Kageyama et al., 1989) many adult tissues. In these experiments, the DNAs of and Sp1 and AP-2 binding sites. Most of these sites peripheral white blood cells (PWBC) from four healthy are located within the 5'-CpG-3'-rich region in individuals, from seven patients with familial HSCR, as proximity to the transcriptional start site.